Email not displaying properly? View email in your browser
Vertical-Talk Pharma   >  Autoimmune Epidemic
>  New Anti-tuberculosis Drug
>  Drug Substance-API
  Aug 2019   e-Newsletter Advertise | Editorial Calendar  
Pall Laboratory
Latest e-book
News
ADC Therapeutics and Freenome Enter...
Moderna Receives FDA Fast Track Designation...
Press Releases
Phillips-Medisize Highlights Innovations...
CMAB and Kintor Announce a New...
Events
03 - 04 Sep 2019
BioManufacturing 2019
17 - 20 Sep 2019
Digital Pharma East 2019
25 -28 Sep 2019
Expopharm - 2019
Articles
>  Facing the Autoimmune Epidemic Prevention and treatment by novel...
Dante J Marciani, President and Chief Scientist, Qantu Therapeutics, Inc.
Particular fucosylated glycans and glycosides, are sole anti-inflammatory immunomodulators that upon binding to the cell-surface receptor DC-SIGN, bias dendritic cells toward a tolerogenic phenotype with production of Treg cells and immunotolerance. This antigen-specific anti-inflammatory response, stimulated by vaccination, would allow the economical treatment and prevention of autoimmune diseases, without....
Techno Trends
> University of Otago Discovered New Drugs to Treat Top Infectious...
> World's Fist-of-its-Kind Drug Delivery Device Launched for Precise...
> UIC's Scientists Develop a Novel Device to Screen Advanced...
Projects
> Lonza Announces to Expand HPAPI Development and Manufacturing...
> Kite Announces Plans to Build a New Manufacturing Industry
> Mapi Pharma to Build a New Sterile Injectable Production Plant...
Qatar Cargo
  Subscribe  |  e-Book Archives  | Advisory Board   
Follow Us Facebook Twitter Google-plus linkedin
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555